BH-501284

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameBH-501284
Drug Alias NameBH501284BH-501284
ClassificationSmall molecules
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlossomHill Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlossomHill Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A